Am J Epidemiol

1. PAULINO TVC, Biiri B, Matisoo-Smith E, Gosling AL, et al
   A scoping review on cardiometabolic risk factors among Pacific Island populations and implications on future research in the region.
   Am J Epidemiol. 2026;195:1807-1817.
   

   >> Share

   
   

   
   BMJ

2. LANG K
   Retatrutide: Triple acting jab for type 2 diabetes lowers blood sugar and boosts weight loss, trial reports.
   BMJ. 2026;393:e102036.
   

   >> Share

   
   
3. TANNE JH
   Trump: Diabetes doctors ejected from conference for handing out paper criticising US administration.
   BMJ. 2026;393:e511576.
   

   >> Share

   
   

   
   Br J Ophthalmol

4. VIGGIANO P, Peto T, Pignataro M, Termite AC, et al
   Proactive treatment regimen with dexamethasone implant for diabetic and post-occlusive macular oedema: the ProDEX-2 study.
   Br J Ophthalmol. 2026 Jun 5:bjo-2025-328550. doi: 10.1136/bjo-2025-328550.
   

   >> Share

   
   

   
   Diabet Med

5. ZAREMBA N, Harrison A, Brown J, Pillay D, et al
   Experiences of receiving and delivering a novel complex intervention for type 1 diabetes and disordered eating: Process evaluation of the Safe management of people with Type 1 diabetes and EAting Disorders studY (STEADY).
   Diabet Med. 2026 Jun 11:e70377. doi: 10.1111/dme.70377.
   

   >> Share

   
   
6. HIRTLE J, Goraya N, Dunlop A, Booth J, et al
   A qualitative enquiry into the lived experiences of women with type 1 diabetes using closed-loop insulin delivery in pregnancy in the CIRCUIT trial.
   Diabet Med. 2026 Jun 11:e70388. doi: 10.1111/dme.70388.
   

   >> Share

   
   
7. YASMIN M, Mukhopadhyay P, Paul B, Mukhopadhyay DK, et al
   Integrated care for type 1 diabetes: The West Bengal model: 24-month follow-up.
   Diabet Med. 2026 Jun 10:e70350. doi: 10.1111/dme.70350.
   

   >> Share

   
   
8. KIM H, Liu C, Li MJ, Wang H, et al
   Diabetes, in-hospital mortality trends and life expectancy loss among a 21.8-million population in Beijing, China, 2012-2024.
   Diabet Med. 2026 Jun 6:e70380. doi: 10.1111/dme.70380.
   

   >> Share

   
   

   
   Diabetes

9. KING AN, Ussher JR
   Focusing on Diastolic Dysfunction to Achieve Consensus With the Term Diabetic Cardiomyopathy.
   Diabetes. 2026 Jun 6:dbi260002. doi: 10.2337/dbi26-0002.
   

   >> Share

   
   
10. STEFAN N
    MASLD as Complication of Diabetes.
    Diabetes. 2026 Jun 6:dbi260001. doi: 10.2337/dbi26-0001.
    

    >> Share

    
    
11. LIPSCOMBE LL, Ali S, Lega IC
    The Link Between Diabetes and Cancer: Converging Mechanistic and Epidemiologic Evidence.
    Diabetes. 2026 Jun 6:dbi260003. doi: 10.2337/dbi26-0003.
    

    >> Share

    
    
12. CRITCHLEY JA, Carey IM, Chaudhry UAR, Bowen L, et al
    Increased Risk of Infections in People Living With Diabetes.
    Diabetes. 2026 Jun 6:dbi260004. doi: 10.2337/dbi26-0004.
    

    >> Share

    
    
13. XU J, Shi J, Hu P, Jiang N, et al
    Inhibition of GLUT1 Ameliorates Thickening of the Glomerular Basement Membrane via the Rheb/mTORC1 Pathway in Diabetic Nephropathy.
    Diabetes. 2026 Jun 8:db250883. doi: 10.2337/db25-0883.
    

    >> Share

    
    
14. BUHLER BD, De Taeye S, Kinoshita K, Terashita M, et al
    The Potential of Composite Pig Islets-Kidney Xenotransplantation to Cure Diabetes and Renal Failure: A Suggested Modified Approach.
    Diabetes. 2026 Jun 9:db250769. doi: 10.2337/db25-0769.
    

    >> Share

    
    
15. WANG N, DiCorpo DA, Zhang Y, Kleinbrink E, et al
    Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program.
    Diabetes. 2026 Jun 11:db250557. doi: 10.2337/db25-0557.
    

    >> Share

    
    
16. LYU S, Wu J, Ma W, Sun L, et al
    Type 2 Diabetes Reduces IFN-alpha2 and Compromises Antiviral Defense: Evidence From Mendelian Randomization and H1N1-Infected Diabetic Mice.
    Diabetes. 2026 Jun 12:db250974. doi: 10.2337/db25-0974.
    

    >> Share

    
    

    
    Diabetes Care

17. JACOBSEN LM, Cuthbertson D, Felton J, Sherr JL, et al
    Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect Profile.
    Diabetes Care. 2026 Jun 12:dc260632. doi: 10.2337/dc26-0632.
    

    >> Share

    
    
18. KAHKONEN O, Kuusela S, Laiho JE, Euren A, et al
    Identification and Follow-up of At-Risk Children Mitigate Disease Severity and Improve Treatment Outcomes in Type 1 Diabetes.
    Diabetes Care. 2026 Jun 11:dc260136. doi: 10.2337/dc26-0136.
    

    >> Share

    
    
19. CLELAND CR, Bascaran C, Makupa WU, Shilio B, et al
    Head-to-Head Comparative Evaluation of Four Commercially Available Artificial Intelligence Systems for Detecting Referable Diabetic Retinopathy in a Tanzanian Population.
    Diabetes Care. 2026 Jun 10:dc260572. doi: 10.2337/dc26-0572.
    

    >> Share

    
    
20. JOHNSEN E, Bengtsson J, Halasa T, Lotfi A, et al
    Achieving at Least 15% Weight Loss Within 2 Years of Type 2 Diabetes Diagnosis Is Associated With Lower Risks of Macrovascular and Microvascular Complications: A U.K. Cohort Study.
    Diabetes Care. 2026 Jun 8:dc260937. doi: 10.2337/dc26-0937.
    

    >> Share

    
    
21. BEERNINK JM, Heerspink HJL, Birkenfeld AL, Cherney DZI, et al
    Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.
    Diabetes Care. 2026 Jun 8:dc260882. doi: 10.2337/dc26-0882.
    

    >> Share

    
    
22. AJJAN RA, Choudhary P, Xu Y, Dunn TC, et al
    Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice.
    Diabetes Care. 2026 Jun 8:dc260398. doi: 10.2337/dc26-0398.
    

    >> Share

    
    
23. 
    Early Pregnancy Glycemic Testing for Prediction of Gestational Diabetes Mellitus and Large for Gestational Age Birth Weight.
    Diabetes Care. 2026 Jun 7:dc260302. doi: 10.2337/dc26-0302.
    

    >> Share

    
    
24. LEITER LA, Giugliano RP, Marston NA, De Ferrari G, et al
    Evolocumab in Patients With High-Risk Diabetes: Results From the VESALIUS-CV Trial.
    Diabetes Care. 2026 Jun 7:dc260847. doi: 10.2337/dc26-0847.
    

    >> Share

    
    
25. VOSSEN LE, Van Netten JJ, Hulshof CM, Jelsma N, et al
    An Integrated Personalized Multimodal Intervention Improves Adherence to Wearing Custom-Made Footwear in People With Diabetes at High Foot Ulcer Risk: A Multicenter Randomized Controlled Trial (DIASSIST).
    Diabetes Care. 2026 Jun 5:dc253113. doi: 10.2337/dc25-3113.
    

    >> Share

    
    
26. PHEE AAT, Foo RX, Guivarch C, Liu P, et al
    Postpartum Dietary Interventions and Cardiometabolic Profiles After Pregnancies Complicated by Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis.
    Diabetes Care. 2026 Jun 5:dc260057. doi: 10.2337/dc26-0057.
    

    >> Share

    
    
27. BISNO DI, Turner LV, Gallop RJ, Jo Kamimoto JL, et al
    Factors Associated With Nocturnal Hypoglycemia After Exercise in the Type 1 Diabetes and Exercise Initiative (T1DEXI) Study.
    Diabetes Care. 2026 Jun 5:dc260381. doi: 10.2337/dc26-0381.
    

    >> Share

    
    

    
    Diabetes Obes Metab

28. CHEN H, Gao J, Zhong WF, Li C, et al
    Intrinsic Capacity, Genetic Susceptibility and Incident Cardiovascular Disease Among Individuals With Diabetes: A Prospective Cohort Study.
    Diabetes Obes Metab. 2026 Jun 10. doi: 10.1111/dom.70990.
    

    >> Share

    
    
29. JOUBERT M, Meyer L, Bekka S, Guerci B, et al
    Mismatch Between Sensor and Symptoms: The Complex Reality of Hypoglycemia Around Exercise in Type 1 Diabetes Patients Using AID Systems.
    Diabetes Obes Metab. 2026 Jun 9. doi: 10.1111/dom.70971.
    

    >> Share

    
    
30. SCHMIDT KR, Johansen RF, Riis SB, Larsen MS, et al
    Pre-Exercise Galactose or Lactose Reduces Glycaemic Excursions During Exercise in Adults With Type 1 Diabetes: A Randomised, Double-Blind, Crossover Trial.
    Diabetes Obes Metab. 2026 Jun 9. doi: 10.1111/dom.70958.
    

    >> Share

    
    
31. VADEN A, Lahelma M, Nurmi L, Heikkila E, et al
    Nationwide Real-World Retrospective Study of Oral Semaglutide Use in Adults Living With Type 2 Diabetes in Finland.
    Diabetes Obes Metab. 2026 Jun 9. doi: 10.1111/dom.70920.
    

    >> Share

    
    
32. CANHA D, Riveline JP, Kazanlieva F, Aguayo GA, et al
    What Is a Clinically Meaningful Change in Diabetes Distress? Findings for Diabetes Care and Research From the SFDT1 Cohort.
    Diabetes Obes Metab. 2026 Jun 12. doi: 10.1111/dom.70932.
    

    >> Share

    
    
33. DE PAULO RS, Bonifacio DB, de Carvalho MHL, Bressan J, et al
    Dietary Strategies and Nutritional Management in Patients Receiving GLP-1 and Dual GIP/GLP-1 Receptor Agonists as Adjuncts to Lifestyle Interventions: A Systematic Review of Randomised Clinical Trials.
    Diabetes Obes Metab. 2026;28:5492-5507.
    

    >> Share

    
    
34. ZHANG Y, Chen H, He L, Bai D, et al
    Mechanism of Terpinen-4-ol in Suppressing beta-Cell Dedifferentiation: Restoring Mitophagy and Alleviating Mitochondrial Calcium Overload via Parkin-Mediated MCU Degradation.
    Diabetes Obes Metab. 2026;28:5871-5892.
    

    >> Share

    
    
35. LU Y, Chen J, Guo Y, Ding H, et al
    Cardiometabolic Profiles of Oral and Subcutaneous Glucagon-Like Peptide-1 Receptor Mono-Agonists in Adults With Overweight or Obesity: A Systematic Review and Network Meta-Analysis.
    Diabetes Obes Metab. 2026;28:5761-5766.
    

    >> Share

    
    
36. MEI G, Xia Y, Gan J, Chen B, et al
    Early-Onset Versus Late-Onset Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Maternal, Perinatal and Neonatal Outcomes.
    Diabetes Obes Metab. 2026 Jun 9. doi: 10.1111/dom.70982.
    

    >> Share

    
    
37. LIARAKOS AL, Randhay A, Leelarathna L, Crabtree TSJ, et al
    Associations Between Patient-Reported Outcomes and Glycaemic Exposure in Continuous Glucose Monitoring Users With Insulin-Treated Diabetes Receiving Haemodialysis.
    Diabetes Obes Metab. 2026 Jun 8. doi: 10.1111/dom.70954.
    

    >> Share

    
    
38. SEGEV N, Nadeau KJ, Kelsey M, Schaaf LR, et al
    Glycemic Normalization Immediately Following Vertical Sleeve Gastrectomy in Adolescents With Type 2 Diabetes From the ST(2)OMP Study.
    Diabetes Obes Metab. 2026 Jun 8. doi: 10.1111/dom.70961.
    

    >> Share

    
    
39. KHIN LM, Fujihara K, Sato T, Yamada T, et al
    Incidence and Associated Factors of Hypertension and Dyslipidemia Improvement in People With Type 2 Diabetes Remission: A Multicenter Real-World Retrospective Cohort Study (JDDM84).
    Diabetes Obes Metab. 2026 Jun 8. doi: 10.1111/dom.70889.
    

    >> Share

    
    
40. CHEN KE, Wang PC, Lin HA, Lin SF, et al
    Risk of Age-Related Ocular Diseases in Non-Diabetic Adults With Obesity Using Glucagon-Like Peptide 1 Receptor Agonists.
    Diabetes Obes Metab. 2026 Jun 8. doi: 10.1111/dom.70975.
    

    >> Share

    
    
41. FADINI GP, Morieri ML, Boscaro C, Bonora BM, et al
    Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal Tolerability.
    Diabetes Obes Metab. 2026;28:6405-6412.
    

    >> Share

    
    
42. CHERNEY DZI, Rossing P, Canziani ME, Caramori ML, et al
    Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses.
    Diabetes Obes Metab. 2026;28:6324-6333.
    

    >> Share

    
    
43. YANG H, Zhong W, Shen S, Gao Y, et al
    Higher Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Associated With Reduced Risk of Prediabetes.
    Diabetes Obes Metab. 2026;28:6254-6264.
    

    >> Share

    
    
44. KALAVALAPALLI S, Leiva EG, Rocha AO, Sharma A, et al
    High Prevalence of Metabolic Dysfunction-Associated Steatohepatitis With Significant Fibrosis in Primary Care and Endocrinology Clinics.
    Diabetes Obes Metab. 2026;28:6184-6193.
    

    >> Share

    
    
45. RUSEVA A, Michalak W, Bassan M, Du EX, et al
    Semaglutide 2.4 mg Cardiometabolic Long-Term Effects in Patients With Obesity or Overweight in a Real-World Setting: A Retrospective Cohort Study in the United States (SMILE).
    Diabetes Obes Metab. 2026;28:6121-6130.
    

    >> Share

    
    
46. ZAGAROLI L, Caione N, Zara S, Guerra F, et al
    Accuracy of ChatGPT, Gemini, Claude and DeepSeek in Carbohydrate Counting.
    Diabetes Obes Metab. 2026;28:5627-5636.
    

    >> Share

    
    

    
    Diabetologia

47. TRIVEDI PM, Catterall T, Sutton VR, Moshovakis V, et al
    Pharmacological inhibition of perforin dampens CD8(+) T cell-mediated beta cell destruction in autoimmune diabetes in mice.
    Diabetologia. 2026 Jun 11. doi: 10.1007/s00125-026-06773.
    

    >> Share

    
    
48. FU Y, Long N, Sourn P, Zhang M, et al
    Gardnerella enrichment in the vaginal microbiome of women with gestational diabetes mellitus is associated with lower fetal birthweight percentiles.
    Diabetologia. 2026 Jun 11. doi: 10.1007/s00125-026-06770.
    

    >> Share

    
    
49. COHENSHTAM O, Zung A, Yu A, King H, et al
    Fetal growth is driven by a bimodal fetal beta cell response and reshaped by a ketogenic diet in a mouse model of maternal diabetes.
    Diabetologia. 2026 Jun 9. doi: 10.1007/s00125-026-06771.
    

    >> Share

    
    
50. MELIN A, Lespagnol E, Combes A, Berthoin S, et al
    The protective effect of high-intensity interval exercise compared with continuous moderate exercise on glycaemic decline is more pronounced in the postabsorptive vs postprandial state in adults with type 1 diabetes: a randomised crossover trial.
    Diabetologia. 2026 Jun 9. doi: 10.1007/s00125-026-06760.
    

    >> Share

    
    
51. CHO A, Nostro MC
    Unravelling the developmental origins of cystic fibrosis-related diabetes.
    Diabetologia. 2026 Jun 9. doi: 10.1007/s00125-026-06768.
    

    >> Share

    
    
52. BILSON J, Yaghootkar H
    Genetics of MASLD: a diabetes perspective.
    Diabetologia. 2026 Jun 8. doi: 10.1007/s00125-026-06759.
    

    >> Share

    
    
53. LI H, Morris L, Bygdell M, Santosa A, et al
    SARS-CoV-2 infection and COVID-19 vaccination and the risk for new-onset type 1 diabetes: a register-based population study in Sweden.
    Diabetologia. 2026 Jun 6. doi: 10.1007/s00125-026-06767.
    

    >> Share

    
    
54. PARR EB, Charrouf R, Hutchison AT, Flint SA, et al
    Time-restricted eating versus dietetic guidance on glycaemic outcomes in adults at risk of type 2 diabetes: a non-inferiority randomised clinical trial.
    Diabetologia. 2026 Jun 6. doi: 10.1007/s00125-026-06762.
    

    >> Share

    
    
55. STENER-VICTORIN E, Carlsson S, Hagstrom H, Taebnia N, et al
    MASLD, diabetes and PMOS across the female life stages.
    Diabetologia. 2026 Jun 5. doi: 10.1007/s00125-026-06761.
    

    >> Share

    
    
56. RYDEN M
    Perspectives on human adipose tissue: from cellular mechanisms to clinical complications.
    Diabetologia. 2026;69:1731-1740.
    

    >> Share

    
    
57. SCHONBACHER L, Walzl AM, Stern C, Kofeler HC, et al
    Short-term modulation of human milk oligosaccharides in plasma and milk by glucose and insulin: insights into postpartum metabolic regulation.
    Diabetologia. 2026;69:2029-2043.
    

    >> Share

    
    
58. GAMACHE I, Fagbemi K, Harnois-Leblanc S, Greenwood CMT, et al
    Nature vs nurture of glucose homeostasis trajectories in children from the ALSPAC study.
    Diabetologia. 2026;69:1962-1974.
    

    >> Share

    
    
59. MURRAY LEECH J, Arni AM, Chundru VK, Sharp LN, et al
    Polygenic background contributes to GCK-MODY clinical presentation and glycaemic variability.
    Diabetologia. 2026;69:1951-1961.
    

    >> Share

    
    
60. YU G, Tam CHT, Shi M, Hughes AE, et al
    Maternal and fetal genetic predispositions to insulin deficiency and resistance affect fetal growth through distinct pathways.
    Diabetologia. 2026;69:1935-1950.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

61. MASUDA T, Katakami N, Taya N, Miyashita K, et al
    Classification of glucose profile in Japanese patients with type 1 diabetes and its association with complications.
    J Clin Endocrinol Metab. 2026 Jun 8:dgag224. doi: 10.1210.
    

    >> Share

    
    

    
    J Nutr

62. BASU A, Richardson LA, Izuora K, Alman AC, et al
    Associations of healthy dietary patterns with plasma biomarkers of inflammation and coagulation in adults with and without type 1 diabetes.
    J Nutr. 2026 Jun 6:101648. doi: 10.1016/j.tjnut.2026.101648.
    

    >> Share

    
    
63. OHKUMA T, Iwase M, Higashi T, Sakamoto W, et al
    Dietary Fiber Intake, FTO Genotypes, and Their Interactions on Obesity-Related Measures: The Fukuoka Diabetes Registry.
    J Nutr. 2026 Jun 6:101481. doi: 10.1016/j.tjnut.2026.101481.
    

    >> Share

    
    

    
    JAMA

64. ANDERER S
    First National Estimates of Type 2 Diabetes in Children Raise Alarm.
    JAMA. 2026 Jun 12. doi: 10.1001/jama.2026.8293.
    

    >> Share

    
    
65. ESSIEN UR, Byhoff E
    Insulin Cost Caps, Trade-Offs, and Pharmacoequity in Diabetes.
    JAMA. 2026 Jun 6. doi: 10.1001/jama.2026.7544.
    

    >> Share

    
    
66. 
    Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes: Research Summary.
    JAMA. 2026 Jun 7:e269759. doi: 10.1001/jama.2026.9759.
    

    >> Share

    
    
67. GADDE KM, Talebloo J, Heymsfield SB
    Mazdutide and Orforglipron-New Evidence in Obesity and Diabetes.
    JAMA. 2026 Jun 7. doi: 10.1001/jama.2026.10443.
    

    >> Share

    
    
68. GIORGINO F, D'Souza S, Ludwig L, Kiyosue A, et al
    Orforglipron Added to Titrated Insulin Glargine in Type 2 Diabetes: The ACHIEVE-5 Randomized Clinical Trial.
    JAMA. 2026 Jun 7:e269512. doi: 10.1001/jama.2026.9512.
    

    >> Share

    
    

    
    Lancet

69. ORTIZ A, Fernandez-Fernandez B
    Finerenone: kidney protection beyond type 2 diabetes.
    Lancet. 2026;407:2348-2350.
    

    >> Share

    
    
70. BAJAJ HS, Welch M, Shah P, Luna E, et al
    Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial.
    Lancet. 2026;407:2402-2413.
    

    >> Share

    
    
71. ROSENSTOCK J, Billings LK, Gajria R, Giorgino F, et al
    Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.
    Lancet. 2026 Jun 7:S0140-6736(26)01022-6. doi: 10.1016/S0140-6736(26)01022.
    

    >> Share

    
    
72. VAN RAALTE DH, Muskiet MHA
    Beyond insulin escalation: REIMAGINE 3 and advanced type 2 diabetes care.
    Lancet. 2026 Jun 7:S0140-6736(26)01074-3. doi: 10.1016/S0140-6736(26)01074.
    

    >> Share

    
    
73. WELCH M, Forst T, Jia W, Del Pino PO, et al
    Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial.
    Lancet. 2026 Jun 8:S0140-6736(26)00800-7. doi: 10.1016/S0140-6736(26)00800.
    

    >> Share

    
    
74. ARODA VR, Davies MJ, Maaske J, Millegard M, et al
    Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trial.
    Lancet. 2026 Jun 8:S0140-6736(26)00802-0. doi: 10.1016/S0140-6736(26)00802.
    

    >> Share

    
    

    
    Metabolism

75. TRYBULSKI R, Zebrowska A, Fostiak K, Olaniszyn G, et al
    Resistance training and diabetes mellitus type 2: An umbrella review of systematic reviews and meta-analyses on glycemic and cardiometabolic outcomes.
    Metabolism. 2026;182:156671.
    

    >> Share

    
    

    
    N Engl J Med

76. GEHRKE EJ, Han IC
    Neovascularization of the Disk in Proliferative Diabetic Retinopathy.
    N Engl J Med. 2026;394:e52.
    

    >> Share

    
    

    
    Nature

77. CALLIER V
    TB vaccine from the 1920s shows promise in diabetes trial.
    Nature. 2026 Jun 9. doi: 10.1038/d41586-026-01825.
    

    >> Share

    
    

    
    Ophthalmol Retina

78. MUSTE JC, Schulgit MJ, Perkins S, Russell M, et al
    Outcomes and Complications of Pars Plana Vitrectomy for Non-clearing Vitreous Hemorrhage without Tractional Elements.
    Ophthalmol Retina. 2026 Jan 28:S2468-6530(26)00024.
    

    >> Share

    
    

    
    Ophthalmology

79. NORDVALL LM
    Re: Liu et al.: Rate and risk of nonarteritic anterior ischemic optic neuropathy with semaglutide use for diabetes and weight loss: a systematic review and meta-analysis (Ophthalmology 2026;133;589-598).
    Ophthalmology. 2026 Jun 12:S0161-6420(26)00365.
    

    >> Share

    
    
80. SOBRIN L
    Diabetic Retinopathy: Genetics Deals the Cards, But Lifestyle Plays the Hand.
    Ophthalmology. 2026 Jun 12:S0161-6420(26)00371.
    

    >> Share

    
    
81. JUMMALA S, C MK, Tripathi S, Sati DM, et al
    Re: Singer et al.: Fluocinolone acetonide implant as a baseline therapy for diabetic macular edema: results from the randomized phase 4 NEW DAY study (Ophthalmology. 2026;133:837-851).
    Ophthalmology. 2026 Jun 12:S0161-6420(26)00373.
    

    >> Share

    
    
82. ABDELAAL A, Serhan HA, Alsaadi M, Yaldo L, et al
    Semaglutide and the Risk of Non-Arteritic Ischemic Optic Neuropathy: A Systematic Review and Certainty of Evidence Meta-Analysis.
    Ophthalmology. 2026 Feb 13:S0161-6420(26)00082.
    

    >> Share

    
    

    
    PLoS One

83. WEI C, Cao C, Xu Z, Chen G, et al
    Association between the triglyceride-glycated hemoglobin index and diabetes risk among patients with Non-alcoholic fatty liver disease: A longitudinal cohort study.
    PLoS One. 2026;21:e0350633.
    

    >> Share

    
    
84. KIBIRIGE D, Olum R, Turyamureeba W, Morgan B, et al
    Prevalence and factors associated with microvascular and macrovascular diabetes complications in adult Ugandans: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0312792.
    

    >> Share

    
    
85. ZURIEGAT L, Itani R, Abu Hammour K, Abu-Farha R, et al
    Multidrug resistance and inappropriate empiric therapy as predictors of hospital stay in diabetic foot infections.
    PLoS One. 2026;21:e0350837.
    

    >> Share

    
    
86. MEKONEN N, Hurisa Z, Selamu E, G/Meskel T, et al
    Magnitude of nonadherence to diet and exercise recommendations and associated factors among type 2 diabetes patients on treatment follow-up at Asella Referral and Teaching Hospital, Arsi, Ethiopia: A cross sectional study.
    PLoS One. 2026;21:e0330576.
    

    >> Share

    
    
87. DENG W, Zhang S, Zhang Y, Wan Q, et al
    Correction: The association between platelet-to-albumin ratio and diabetic peripheral neuropathy: A cross-sectional study in the Chinese population.
    PLoS One. 2026;21:e0351559.
    

    >> Share

    
    
88. ALRIYAMI M, Malehi AS, Al Kamyani A, Al Jabri F, et al
    Type 2 diabetes and cancer: A retrospective longitudinal comparative cohort study of disease sequence and comorbidity profiles.
    PLoS One. 2026;21:e0350276.
    

    >> Share

    
    
89. TOMEMORI R, Mori H, Tanaka M, Kiriishi T, et al
    Real-world outcomes after switching to faricimab in treatment-resistant diabetic macular edema: A 1-year observational study with choroidal thickness assessment.
    PLoS One. 2026;21:e0351168.
    

    >> Share

    
    
90. CHEN Q, Chen T, Lin W, Chen X, et al
    Cost-effectiveness of semaglutide versus dulaglutide for Type 2 Diabetes in China: A Markov Model analysis.
    PLoS One. 2026;21:e0351059.
    

    >> Share

    
    
91. FEREDE YM, Westerbotn M, Gebrie MH, Beshah DT, et al
    Translation, cultural adaptation, and psychometric evaluation of the Patient Assessment Chronic Illness Care tool in Ethiopia (PACIC-5As-ET) for patients with type 2 diabetes.
    PLoS One. 2026;21:e0329197.
    

    >> Share

    
    
92. HASAN A, Alobaidly A, Alkouri O, Ahmed FR, et al
    Lived experiences of type 2 diabetes self-management in Jordan: A qualitative study of sociocultural, religious, and healthcare influences.
    PLoS One. 2026;21:e0350641.
    

    >> Share

    
    
93. YU W, Chen H, Shi L, Gao G, et al
    Identification of non-cardiomyocytes marker genes in patients with diabetes and cardiomyopathy through single-cell analysis.
    PLoS One. 2026;21:e0351057.
    

    >> Share

    
    

    
    Retina

94. ALSHAIKHSALAMA AM, Abdi A, Talapathy T, Kim JE, et al
    Diabetic Retinopathy Outcomes Among Unhoused Individuals: A Big Data Analysis.
    Retina. 2026 Jun 9. doi: 10.1097/IAE.0000000000004904.
    

    >> Share

    
    

    
    Transplant Proc

95. SHIMAOKA T, Sasaki K, Akita H, Mukai Y, et al
    Simultaneous Pancreas and Kidney Transplantation in a Patient With Congenital Hemophilia A: A rare Case Report and Management Insights.
    Transplant Proc. 2026 May 18:S0041-1345(26)00226.
    

    >> Share

    
    

    
    WMJ

96. VUNNAM DS, Moore SE, Pathak RD
    Starvation Ketosis Versus Euglycemic Diabetic Ketoacidosis in Pregnancy: A Case Report Highlighting the Diagnostic Overlap.
    WMJ. 2026;125:323-326.
    

    >> Share

    
    
97. FOLEY O, Tauseef A, Brenner J
    The Influence of Falsely Low HbA1c Levels in Diabetes Patients With Hereditary Hemorrhagic Telangiectasia: The Need for Alternative Diagnostic Approaches.
    WMJ. 2026;125:309-311.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share